Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group

Clicks: 322
ID: 120499
1993
Administration of high doses of respiratory syncytial virus immune globulin is a safe and effective means of preventing lower respiratory tract infection in infants and young children at high risk for this disease.
Reference Key
jr1993theprophylactic Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Groothuis JR;Simoes EA;Levin MJ;Hall CB;Long CE;Rodriguez WJ;Arrobio J;Meissner HC;Fulton DR;Welliver RC;;
Journal The New England journal of medicine
Year 1993
DOI DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/8413475
Keywords
immunization National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine logistic models research support non-u.s. gov't u.s. gov't female male Infant newborn P.H.S. risk factors Clinical Trial Randomized Controlled Trial Antibodies Multicenter Study immunoglobulins intravenous / therapeutic use* r c welliver respiratory syncytial virus infections / immunology respiratory syncytial virus infections / prevention & control* passive* respiratory syncytial viruses / immunology intravenous / administration & dosage heart defects opportunistic infections / prevention & control* viral / administration & dosage premature diseases / prevention & control* j r groothuis e a simoes bronchopulmonary dysplasia / complications congenital / complications diseases / immunology pmid:8413475 doi:10.1056/nejm199311183292102

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.